Bristol Myers Squibb was named Pharma Industry Company of the Year in the recently concluded Pharma Industry Awards 2025, exemplifying excellence, innovation, and leadership within Ireland’s life sciences sector.

The company has been recognised for its unwavering commitment to healthcare innovation, advancing medical science while prioritising patient wellbeing. Judges praised Bristol Myers Squibb for combining scientific rigour with compassion and collaboration, fostering breakthroughs that truly change lives. 

“Our winner stands as a driving force in healthcare innovation, advancing medical science through a deep commitment to research and patient wellbeing,” the panel noted. Their work continues to set industry benchmarks, demonstrating how purpose, passion, and integrity can transform healthcare outcomes.

The award underscores Bristol Myers Squibb’s unwavering commitment to quality, innovation, and service excellence—principles that have consistently defined its impact within Ireland’s dynamic pharmaceutical sector. 

The Pharma Industry Awards 2025 gala was held on Thursday, 20 November at the Dublin Royal Convention Centre. It brought senior executives, innovators, and key decision-makers together to celebrate the organisations and individuals driving the country’s life sciences landscape forward. 

Building on this achievement, Bristol Myers Squibb’s recognition not only honours its accomplishments but also sets a benchmark for emerging innovators, inspiring the next generation of entries for the Pharma Industry Awards 2026 to push boundaries, deliver breakthroughs, and shape the future of medicine in Ireland.

Who will rise to take the spotlight next year and continue to redefine excellence in Ireland’s pharmaceutical industry?

Discover the full list of winners and their remarkable achievements on the official website, and stay informed on category updates, industry insights, and future awards by subscribing to our newsletter.